Siegfried Holding AG Logo

Siegfried Holding AG

A global CDMO developing and manufacturing APIs and finished drug products for pharma.

SFZN | SW

Overview

Corporate Details

ISIN(s):
CH0014284498 (+3 more)
LEI:
506700J9QD6IF3937W06
Country:
Switzerland
Address:
Untere Brühlstrasse 4, 4800 Zofingen

Description

Siegfried Holding AG is a global contract development and manufacturing organization (CDMO) serving the pharmaceutical industry. The company's core activities involve the development and manufacturing of active pharmaceutical ingredients (APIs), intermediates, and finished drug products. Its portfolio of finished dosage forms includes tablets, capsules, sterile vials, and ampoules. Siegfried provides an integrated service model, supporting partners from process development through to commercial-scale production. The company is also expanding its capabilities into specialized areas, including ophthalmic drugs and viral vectors for cell and gene therapies.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-07-10 02:00
Marcel Imwinkelried appointed as new CEO
English 9.2 KB
2024-07-02 06:30
Siegfried successfully completes acquisition of an early-phase CDMO in Wisconsi…
English 12.2 KB
2024-07-02 02:00
Siegfried successfully completes acquisition of an early-phase CDMO in Wisconsi…
English 9.3 KB
2024-06-14 06:30
EGS Beteiligungen AG exercises right to convert bond and increases its sharehol…
English 11.9 KB
2024-06-14 02:00
EGS Beteiligungen AG exercises right to convert bond and increases its sharehol…
English 9.4 KB
2024-06-12 06:30
Siegfried to acquire an early-phase CDMO in Wisconsin (US) to strengthen its Dr…
English 18.4 KB
2024-06-12 02:00
Siegfried to acquire an early-phase CDMO in Wisconsin (US) to strengthen its Dr…
English 15.1 KB

Automate Your Workflow. Get a real-time feed of all Siegfried Holding AG filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Siegfried Holding AG

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Siegfried Holding AG via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2024-10-31 N/A Executive member Sell None 1,695,000.00 CHF
2024-10-31 N/A Executive member Sell None 1,584,260.00 CHF
2024-08-28 N/A Executive member Sell None 1,086,000.00 CHF
2024-08-28 N/A Executive member Sell None 380,100.00 CHF
2024-08-28 N/A Executive member Sell None 362,724.00 CHF
2024-06-14 N/A Non-Executive member Sell None 368,930.00 CHF
2024-03-06 N/A Executive member Sell None 4,587,500.00 CHF
2024-03-06 N/A Executive member Sell None 1,376,250.00 CHF
2024-03-06 N/A Executive member Sell None 917,500.00 CHF
2024-03-06 N/A Executive member Sell None 458,750.00 CHF

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.